F1000Prime recommendation of Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study.

@inproceedings{Truwit2013F1000PrimeRO,
  title={F1000Prime recommendation of Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study.},
  author={Jonathon D Truwit},
  year={2013}
}

Topics from this paper.